Growth Inhibition of Kirkman-Robbins Hepatoma by l-(l,3-Dihydroxy-2-propoxymethyl)-5,6-tetramethyIeneuraciI and Possible Mechanism of its Biological Activity

Autor: Greger, Janusz, Dramiriski, Marcin
Zdroj: Zeitschrift für Naturforschung C; December 1989, Vol. 44 p985-991, 7p
Abstrakt: Hepatoma, Acyclonucleoside Metabolism , dN and dTMP Kinases. dNTP Pool l-(l,3-D ihydroxy-2-propoxym ethyl)-5,6-tetram ethylene-uracil (DHPTU) is a newly synthe­ sized acyclonucleoside which shows cytostatic properties. It was tested in Syrian hamster 6 days after heterotransplantation of Kirkm an-Robbins hepatoma. A reduction of tumour weight by 61% was found 48 h after its intraperitoneal (i.p .) administration in doses of 20 mg per kg of body weight. Inhibition of tumour growth is accompanied by a reduction of dThd, dGuo and dTMP kinase activities in tumourcytosol (by 91% and 74% and 55% , respectively) and decrease in contents of dTTP, dGTP and dA TP (by 92% , 77% and 67% , respectively) in dNTP pool. DHPTU is not phosphorylated by any tumour dN kinases, but undergoes cleavage with TU release in reaction catalyzed by the tumour cell enzyme, com petitively inhibited by FA . After [14C]DHPTU or [14C]TU had been given i.p. to the animals with the tumour, 90% of the subcellu­lar fraction labelling fell into the nuclear fraction. How ever, if [l4C ]DHPTU was administered with FA and DCF, 27% of radioisotope was found in the nuclear fractions and 68% in cytosol. Since D C F which prevented FA deamination to FB (which is not an inhibitor of the mentioned enzyme) reduces DHPTU-induced changes in activity of dN kinases and dTMP kinase in hepato­ ma cells, the cytostatic activity of DHPTU seems to be connected to an enzyme which releases TU from DHPTU .
Databáze: Supplemental Index